NGN-101

DB18335InvestigationalGene Therapies

NGN-101 is an adeno-associated virus serotype 9 vector with engineered transgene encoding the human CLN5 gene.

Code names
NGN-101

What you can answer from here — as of September 25, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of NGN-101, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In